Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy
Authors
Keywords
-
Journal
Pharmaceutics
Volume 13, Issue 8, Pages 1221
Publisher
MDPI AG
Online
2021-08-09
DOI
10.3390/pharmaceutics13081221
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bifunctional Aptamer–Doxorubicin Conjugate Crosses the Blood–Brain Barrier and Selectively Delivers Its Payload to Epithelial Cell Adhesion Molecule-Positive Tumor Cells
- (2020) Joanna Macdonald et al. Nucleic Acid Therapeutics
- Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
- (2020) Zihua Zeng et al. Cancers
- Doxorubicin conjugated innovative 16-mer DNA aptamer based annexin A1 targeted anti-cancer drug delivery
- (2020) Rohit Bavi et al. Molecular Therapy-Nucleic Acids
- Aptamer‐Engineered Natural Killer Cells for Cell‐Specific Adaptive Immunotherapy
- (2019) Shuanghui Yang et al. Small
- CD30 aptamer-functionalized PEG-PLGA nanoparticles for the superior delivery of doxorubicin to anaplastic large cell lymphoma cells
- (2019) Xiao Luo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Selection of a novel DNA aptamer against OFA/iLRP for targeted delivery of doxorubicin to AML cells
- (2019) Yacong An et al. Scientific Reports
- Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
- (2019) Fadwa Odeh et al. MOLECULES
- Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy
- (2019) Xing Guo et al. PROGRESS IN MATERIALS SCIENCE
- Aptamer-targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7-positive tumours
- (2018) Mengting Liu et al. CELL PROLIFERATION
- Self-Assembled Aptamer-Nanomedicine for Targeted Chemotherapy and Gene Therapy
- (2017) Nianxi Zhao et al. Small
- Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
- (2015) David Porciani et al. Molecular Therapy-Nucleic Acids
- New Insights into the Mechanism of the DNA/Doxorubicin Interaction
- (2014) Cristina Pérez-Arnaiz et al. JOURNAL OF PHYSICAL CHEMISTRY B
- Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
- (2014) Hongguang Sun et al. Molecular Therapy-Nucleic Acids
- Doxorubicin, DNA torsion, and chromatin dynamics
- (2013) Fan Yang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Immunotherapy of CD30-expressing lymphoma using a highly stable ssDNA aptamer
- (2013) Parag Parekh et al. BIOMATERIALS
- Antifreeze glycopeptide diastereomers
- (2012) Lilly Nagel et al. Beilstein Journal of Organic Chemistry
- Lysosomal Acidification Mechanisms
- (2011) Joseph A. Mindell Annual Review of Physiology
- Targeted drug delivery to tumors: Myths, reality and possibility
- (2011) You Han Bae et al. JOURNAL OF CONTROLLED RELEASE
- Design, Synthesis, and Biological Evaluation of a Robust, Biodegradable Dendrimer
- (2010) Derek G. van der Poll et al. BIOCONJUGATE CHEMISTRY
- Development of DNA aptamers using Cell-SELEX
- (2010) Kwame Sefah et al. Nature Protocols
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Novel deprotection method of Fmoc group under neutral hydrogenation conditions
- (2008) Tomohiro Maegawa et al. AMINO ACIDS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started